Short Interest in Health In Tech, Inc. (NASDAQ:HIT) Decreases By 68.8%
by Jessica Moore · The Cerbat GemHealth In Tech, Inc. (NASDAQ:HIT – Get Free Report) saw a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 132,749 shares, a drop of 68.8% from the November 30th total of 425,649 shares. Based on an average daily trading volume, of 763,353 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the company are sold short. Currently, 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 763,353 shares, the days-to-cover ratio is currently 0.2 days.
Hedge Funds Weigh In On Health In Tech
A number of institutional investors and hedge funds have recently added to or reduced their stakes in HIT. Raymond James Financial Inc. bought a new position in Health In Tech in the 3rd quarter worth approximately $45,000. Squarepoint Ops LLC acquired a new position in Health In Tech during the 3rd quarter worth $46,000. Millennium Management LLC acquired a new position in Health In Tech during the 3rd quarter worth $85,000. Cubist Systematic Strategies LLC bought a new position in shares of Health In Tech in the first quarter worth $41,000. Finally, Arete Wealth Advisors LLC bought a new position in shares of Health In Tech in the first quarter worth $47,000.
Health In Tech Price Performance
Shares of HIT stock traded up $0.01 during trading hours on Friday, reaching $1.53. The stock had a trading volume of 170,345 shares, compared to its average volume of 1,002,410. Health In Tech has a twelve month low of $0.51 and a twelve month high of $7.59. The firm has a 50-day simple moving average of $1.89 and a 200-day simple moving average of $2.11. The firm has a market capitalization of $87.07 million and a PE ratio of 51.00.
Health In Tech (NASDAQ:HIT – Get Free Report) last posted its earnings results on Wednesday, November 12th. The company reported $0.01 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.01. The firm had revenue of $8.49 million for the quarter, compared to analyst estimates of $7.05 million.
Wall Street Analysts Forecast Growth
HIT has been the subject of a number of recent research reports. Wall Street Zen downgraded shares of Health In Tech from a “buy” rating to a “hold” rating in a research report on Sunday, November 16th. Weiss Ratings restated a “sell (d-)” rating on shares of Health In Tech in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $2.50.
Check Out Our Latest Stock Report on HIT
Health In Tech Company Profile
Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.